2,729
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US

, , , , , , , , & show all
Pages 669-680 | Received 12 Nov 2015, Accepted 18 Dec 2015, Published online: 13 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Minyuan Chen, Puhong Zhang, Yang Zhao, Nadila Duolikun & Linong Ji. (2022) Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China. Diabetes, Metabolic Syndrome and Obesity 15, pages 3375-3385.
Read now
Karen McGuigan, Alyson Hill, Vivien Coates, Maurice O’Kane, David R Thompson, Chantal F Ski & Deirdre McCay. (2022) Moderating the relationship between diabetes distress and mastery: the role of depression and empowerment. Psychology, Health & Medicine 27:4, pages 838-847.
Read now
Samaneh Kalirai, Jasmina I Ivanova, Magaly Perez-Nieves, Judith J Stephenson, Irene Hadjiyianni, Michael Grabner, Roy Daniel Pollom, Caroline Geremakis, Beverly L Reed & Lawrence Fisher. (2020) Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States. Diabetes, Metabolic Syndrome and Obesity 13, pages 1023-1033.
Read now
Thomas Wilke, Nils Picker, Sabrina Mueller, Silke Geier, Johannes Foersch, Jens Aberle, Stephan Martin, Matthias Riedl & Maximilian Gabler. (2019) Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage. Diabetes, Metabolic Syndrome and Obesity 12, pages 1225-1237.
Read now
Lawrence Blonde, Chakkarin Burudpakdee, Victoria Divino, Brahim Bookhart, Jennifer Cai, Michael Pfeifer & Craig I. Coleman. (2018) The impact of non-medical switch on type 2 diabetes patients treated with canagliflozin in the commercially insured US population. Current Medical Research and Opinion 34:8, pages 1501-1511.
Read now
Theresa L. Garnero, Nichola J. Davis, Magaly Perez-Nieves, Irene Hadjiyianni, Dachuang Cao, Jasmina I. Ivanova & Mark Peyrot. (2018) Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy. Postgraduate Medicine 130:4, pages 394-401.
Read now
Tessa Kennedy-Martin, Kristina S Boye & Xiaomei Peng. (2017) Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Preference and Adherence 11, pages 1103-1117.
Read now
Mark Peyrot, Magaly Perez-Nieves, Jasmina Ivanova, Dachuang Cao, Luke Schmerold, Samaneh Kalirai & Irene Hadjiyianni. (2017) Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational survey. Current Medical Research and Opinion 33:10, pages 1843-1851.
Read now
Magaly Perez-Nieves, Jasmina I. Ivanova, Irene Hadjiyianni, Chen Zhao, Dachuang Cao, Luke Schmerold, Samaneh Kalirai, Sarah King, Amy M. DeLozier, Howard G. Birnbaum & Mark Peyrot. (2017) Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey. Current Medical Research and Opinion 33:10, pages 1833-1842.
Read now

Articles from other publishers (24)

Maya Allen-Taylor, Laura Ryan, Kirsty Winkley & Rebecca Upsher. (2022) Exploring the Experiences and Perspectives of Insulin Therapy in Type 2 Diabetes via Web-Based UK Diabetes Health Forums: Qualitative Thematic Analysis of Threads. JMIR Diabetes 7:4, pages e34650.
Crossref
Devin Steenkamp, Elizabeth L Eby, Nany Gulati & Birong Liao. (2021) Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem. Journal of Diabetes Science and Technology 16:4, pages 995-1002.
Crossref
Marc Evans, Susanne Engberg, Mads Faurby, João Diogo Da Rocha Fernandes, Pollyanna Hudson & William Polonsky. (2021) Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes, Obesity and Metabolism 24:3, pages 377-390.
Crossref
Liwei Zhao, Carolyn E. Cesta & Laura Pazzagli. (2020) The role of socioeconomic factors on discontinuation of insulin during pregnancy—methodological challenges from a Swedish register-based study. Journal of Public Health 30:2, pages 487-494.
Crossref
Karen McGuigan, Alyson Hill, Deirdre McCay, Maurice O’Kane & Vivien Coates. (2021) Overcoming Barriers to Injectable Therapies: Development of the ORBIT Intervention Within a Behavioural Change Framework. Frontiers in Clinical Diabetes and Healthcare 2.
Crossref
Jianmin Wu, Fritha Morrison, Zhenxiang Zhao, Ginger Haynes, Xuanyao He, Ayad K. Ali, Maria Shubina, Shervin Malmasi, Wendong Ge, Xiaomei Peng & Alexander Turchin. (2021) Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study. Clinical Diabetes and Endocrinology 7:1.
Crossref
Fu‐Shun Yen, James Cheng‐Chung Wei, Jia‐Sin Liu, Chih‐Cheng Hsu & Chii‐Min Hwu. (2020) Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study. Journal of Diabetes Investigation 12:2, pages 146-154.
Crossref
Fu-Shun Yen, James Cheng-Chung Wei, Jia-Sin Liu, Chih-Cheng Hsu & Chii-Min Hwu. (2020) The factors associated with insulin nonpersistence in persons with type 2 diabetes. Diabetes Research and Clinical Practice 167, pages 108356.
Crossref
Jieling ChenRadhika NairMir SiadatyKatelyn BrownYunus MeahApril Dawn TaylorXuanyao HeLudi Fan. (2020) Treatment Patterns and Characteristics of Individuals Initiating High-Dose Insulin for Type 2 Diabetes Mellitus. Journal of Managed Care & Specialty Pharmacy 26:7, pages 839-847.
Crossref
Puhong Zhang, Heng Zhang, Xian Li, Minyuan Chen, Du Wang & Linong Ji. (2020) Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus. Endocrinology, Diabetes & Metabolism 3:2.
Crossref
Rajesh R. Mehta, Alison M. Edwards, Swapnil Rajpathak, Ajay Sharma, Kenneth J. Snow & Kristy Iglay. (2020) Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis. Journal of Clinical & Translational Endocrinology 19, pages 100215.
Crossref
K. Winkley, R. Upsher, W. H. Polonsky & E. Holmes‐Truscott. (2019) Psychosocial aspects and contributions of behavioural science to medication‐taking for adults with type 2 diabetes. Diabetic Medicine.
Crossref
Steven V. EdelmanAnastasia ErmakovaYan XiongRay SieradzanStephanie D. Taylor. (2019) Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study. Journal of Managed Care & Specialty Pharmacy 25:12, pages 1420-1431.
Crossref
Daniel J. Kent, Cheryl N. McMahill-Walraven, Catherine A. Panozzo, Pamala A. Pawloski, Kevin Haynes, James Marshall, Jeffrey Brown, Bernadette EichelbergerCatherine M. Lockhart. (2019) Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus. Journal of Managed Care & Specialty Pharmacy 25:11, pages 1162-1171.
Crossref
Denise Reis Franco, Magaly Perez-Nieves, Jasmina I Ivanova, Dachuang Cao & Marcela Saturnino Caselato Vaz. (2019) Basal insulin persistence in Brazilian participants with T2DM. Revista da Associação Médica Brasileira 65:10, pages 1254-1264.
Crossref
Carol M. Hamersky, Moshe Fridman, Cory L. Gamble & Neeraj N. Iyer. (2019) Injectable Antihyperglycemics: A Systematic Review and Critical Analysis of the Literature on Adherence, Persistence, and Health Outcomes. Diabetes Therapy 10:3, pages 865-890.
Crossref
Iskandar Idris, Kunal Gulati, Magaly Perez-Nieves, Irene Hadjiyianni, Dachuang Cao, Arash Tahbaz, Jasmina Ivanova & Syed Wasi Hassan. (2019) Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample. Primary Care Diabetes 13:2, pages 106-112.
Crossref
Jennifer D. Goldman, Jasvinder Gill, Tony Horn, Timothy Reid, Jodi Strong & William H. Polonsky. (2018) Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program. Diabetes Therapy 9:5, pages 2143-2153.
Crossref
Magaly Perez-Nieves, Kristina S. Boye, Jacek Kiljanski, Dachung Cao & Maureen J. Lage. (2018) Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes. Diabetes Therapy 9:3, pages 1099-1111.
Crossref
Vanita R. Aroda, Joseph R. Arulandu & Anthony J. Cannon. (2018) Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?. Clinical Diabetes 36:2, pages 138-147.
Crossref
Samaneh Kalirai, Judith Stephenson, Magaly Perez-Nieves, Michael Grabner, Irene Hadjiyianni, Caroline Geremakis, Roy Daniel Pollom, Beverly Reed & Lawrence Fisher. (2018) Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus. Primary Care Diabetes 12:2, pages 155-162.
Crossref
William H. Polonsky, Joyce Arsenault, Lawrence Fisher, Pamela Kushner, Eden M. Miller, Teresa L. Pearson, Mariusz Tracz, Stewart Harris, Norbert Hermanns, Bernd-M. Scholz, Robyn K. Pollom, Magaly Perez-Nieves, Roy Daniel Pollom & Irene Hadjiyianni. (2017) Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully. International Journal of Clinical Practice 71:8, pages e12973.
Crossref
Samaneh Kalirai, Ran Duan, Dongju Liu & Beverly L. Reed. (2017) Economic Impact of Treatment Duration and Persistence with Basal Insulin in Previously Insulin-Naive Users. Journal of Managed Care & Specialty Pharmacy 23:3, pages 327-336.
Crossref
Irene Hadjiyianni, Urvi Desai, Shuichi Suzuki, Jasmina I. Ivanova, Dachuang Cao, Noam Y. Kirson, Dai Chida, Caroline Enloe, Howard G. Birnbaum & Magaly Perez-Nieves. (2016) Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan. Diabetes Therapy 8:1, pages 149-166.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.